These findings suggest that Sch B has therapeutic potential for MASLD
To date, results from the phase III clinical trials showed that both the Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) mRNA vaccines achieved 9095% efficacy in protecting against COVID-19 (refs 1,2 ), while the AdV vaccines (ChAdOx1 nCoV-19) and Gam-COVID-vac (Sputnik V) showed protection at a slightly lower efficacy (average 70% and 91%, respectively) 3,4
However, phentermine is oral (no injections), easier to access as a generic option, and covered by many insurance plans
Pembrolizumab (Keytruda) and nivolumab (Opdivo), both approved by the FDA in 2014, have become frontline medication for metastatic melanoma
The role of haptoglobin polymorphism in cardiovascular disease in the setting of diabetes
Eur Heart J 39(33):30213104